Morgan Stanley Upgrades Gilead Sciences To Overweight, Shares Rise
Analysts at Morgan Stanley upgraded Gilead Sciences Inc. (NASDAQ: GILD) from undefined to Overweight.
Gilead Sciences shares have jumped 24.92% over the past 52 weeks, while the S&P 500 index has gained 13.45% in the same period.
Gilead Sciences' shares rose 1.92% to $95.59 in pre-market trading.
Latest Ratings for GILD
|Nov 2016||Stifel Nicolaus||Initiates Coverage On||Buy|
|Nov 2016||Mizuho||Initiates Coverage On||Buy|
|Nov 2016||BMO Capital||Upgrades||Market Perform||Outperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.